Acute high-dose MitoQ does not increase urinary kidney injury markers in healthy adults: a randomized crossover trial

Braxton A. Linder, Nina L. Stute, Zach J. Hutchison, Alex M. Barnett, McKenna A. Tharpe, Andreas N. Kavazis, Danielle L. Kirkman, Orlando M. Gutiérrez, Austin T. Robinson

American Journal of Physiology-Renal Physiology · 2023 · 12 citations · 30 references

DOIFull text

Open access

Concepts

Abstract

We found acute high-dose mitochondria-targeted antioxidant (MitoQ) supplementation was not nephrotoxic and had no effect on markers of acute kidney injury in healthy adults. These findings can help bolster further confidence in the safety of MitoQ, particularly for future investigations seeking to examine the role of mitochondrial oxidative stress, via acute MitoQ supplementation, on various physiological outcomes.

References

30